Results 121 to 130 of about 4,515 (264)

Comparative characteristics of eye drops used for the treatment of glaucoma in an experimental model of dry eye

Российский офтальмологический журнал
Purpose of the work is a comparative study of the effect of different concentrations of the excipient carbomer on the local bioavailability and local irritant effect of brinzolamide and timolol in an experimental model of dry eye syndrome (DES). Material
E. V. Blinova, E. A. Litvin, D. S. Blinov, A. A. Galchin, M. V. Shikh, I. S. Struts, K. D. Blinov, S. D. Yudina, O. V. Sergeeva, S. E. Zotov, E. V. Shikh   +10 more
doaj   +1 more source

Topical pharmacokinetics of brinzolamide suspensions in rabbits and variability analysis for sample size and design considerations

, 2023
Vatsala Naageshwaran, Hélène Bigonne, Glenwood G. Gum, Spundana Malla, Charity del Sol, Charles Bon, Xiaoming Xu, Anh Q. Vo, William C. Smith, André O’Reilly Beringhs, Darby Kozak, Ming‐Liang Tan, Andrew Babiskin, Arto Urtti, Eva M. del Amo, Veli‐Pekka Ranta   +15 more
openalex   +1 more source

Effects of Antiglaucoma Drugs on Calcium Mobility in Cultured Corneal Endothelial Cells

Kaohsiung Journal of Medical Sciences, 2006
The aim of this study was to estimate the effects of various antiglaucoma drugs including betaxolol, timolol, levobunolol, brimonidine, carteolol, dipivefrin, dorzolamide, brinzolamide, latanoprost, unoprostone, and pilocarpine on intracellular free Ca2+
Kwou-Yeung Wu, Show-Jen Hong, Hwei-Zu Wang   +2 more
doaj   +1 more source

Ophthalmic Drugs 2015 [PDF]

A handy reference about ophthalmic drugs for students and clinicians in eye care ...
Helmus, Julie A, Koh, Len V
core   +1 more source

Efficacy and tolerability of brinzolamide/brimonidine suspension and prostaglandin analogs in patients previously treated with dorzolamide/timolol solution and prostaglandin analogs

Clinical Ophthalmology, 2016
Jonathan S Lo,1 Pierre M Pang,2 Samuel C Lo3 1John A. Burns School of Medicine, University of Hawaii, Honolulu, Hawaii, 2MD-Pacific Eye Surgery Center, Honolulu, Hawaii, 3MD-Laser and Eye Surgery Center, Honolulu, Hawaii, USA Objective: Fixed ...
Lo JS, Pang PM, Lo SC
doaj  

Effect of prophylactic intraocular pressure-lowering medication (brinzolamide) on intraocular pressure after ranibizumab intravitreal injection: A case–control study

Indian Journal of Ophthalmology, 2016
Purpose: To observe the effect of prophylactic intraocular pressure (IOP)-lowering medication (brinzolamide) on IOP after ranibizumab intravitreal injections (IVIs).
Shuang Song, Xiao-bing Yu, Hong Dai
doaj   +1 more source

BRINZOLAMIDE-LOADED ETHO-LECIPLEX FOR EFFECTIVE OCULAR MANAGEMENT OF GLAUCOMA: D-OPTIMAL DESIGN OPTIMIZATION AND IN VIVO EVALUATION

International Journal of Applied Pharmaceutics
Objective: Brinzolamide (BRZ) is an active carbonic anhydrase inhibitor adopted for glaucoma management. The limited aqueous solubility of the drug restricts its potential for ocular administration.
Sara Nageeb El-Helaly, H. Hammoodi, M. I. Tadros, Nermeen A. Elkasabgy   +3 more
semanticscholar   +1 more source

Patent Clutter [PDF]

, 2018
Patent claims are supposed to clearly and succinctly describe the patented invention, and only the patented invention. This Article hypothesizes that a substantial amount of language in patent claims is in fact not about the core invention, which may ...
Freilich, Janet
core   +1 more source

Thermosensitive Brinzolamide in situ Gel Nanoemulsions, in vitro and ex vivo Evaluation

, 2020
Mohammad Mehdi Mahboobian, G Anaraki Mohammadi, Mojdeh Mohammadi, R Soufdoost, M Yazdanian, E Tahmasebi, A Yazdanian, H Tebyanian, A Karami, M Nourani, Y Panahi, R Gaudana, H Ananthula, A Parenky, A Mitra, Y Ali, K Lehmussaari, F Shakeri, H Tebyanian, A Karami, H Babavalian, M Tahmasbi, A Karami, H Tebyanian, A Barkhordari, E Motavallian, R Soufdoost, M Nourani, N Gooch, S Molokhia, R Condie, R Burr, B Archer, B Ambati, B Wirostko, C Reeder, M Franklin, T Bramley, W Alward, R Saxena, J Prakash, P Mathur, S Gupta, H Babavalian, A Latifi, M Shokrgozar, S Bonakdar, H Tebyanian, F Shakeri, K Edsman, J Carlfors, R Petersson, M Iester, R Moosavi, E Ansari, F Wang, X Bao, A Fang, H Li, Y Zhou, Y Liu, C Jiang, J Wu, X Song, J Young, J Clements, J Morrison, H Takusagawa, R Van Der Valk, C Webers, J Schouten, M Zeegers, F Hendrikse, M Prins, Y Dong, S Huang, J Cui, T Yoshitomi, S Lerner, F Oddone, D Lu, A Sanseau, M Guarro, A Ridolfi, D Hubatsch, P Rajpoot, K Pathak, V Bali, C Solans, P Izquierdo, J Nolla, N Azemar, M Garcia-Celma, Q Liu, H Huang, H Chen, J Lin, Q Wang, R Soufdoost, S Mosaddad   +99 more
openalex   +1 more source

NGHIÊN CỨU ĐIỀU TRỊ BỆNH HẮC VÕNG MẠC TRUNG TÂM THANH DỊCH BẰNG DUNG DỊCH NHỎ MẮT BRINZOLAMIDE 1%

Tạp chí Y học Việt Nam
Mục tiêu: Đánh giá kết quả điều trị bệnh hắc võng mạc trung tâm thanh dịch bằng dung dịch nhỏ mắt Brinzolamide 1% (Azopt). Đối tượng và phương pháp nghiên cứu: Nghiên cứu can thiệp lâm sàng ngẫu nhiên có đối chứng trên 58 mắt của 54 bệnh nhân được ...
M. Vũ, Cương Hoàng, Quốc Tùng Mai
semanticscholar   +1 more source